Blog Post

Staging of Neuroendocrine Neoplasms (NENs)

Translate
Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 14.5K other subscribers

Stage of cancer

What is stage?  The extent of a cancer in the body. Staging is usually based on the size of the tumour, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.

What are the stage numbers?  Most types of cancer have 4 stages, numbered from 1 to 4 indicating a rising spread as the number is bigger. Some cancer have a stage 0 but I don’t believe this applies to Neuroendocrine Neoplasms (NENs).  Often doctors write the stage down in Roman numerals, so you may see stages written as I, II, III and IV. 

Wil my staging ever change? You may be given an initial staging based on physical examination, imaging tests, and biopsies of affected areas.  After any surgery, pathologists combine the results of both the clinical staging with the surgical results which may result in an update.  In certain scenarios, a recurrence or retreatment staging is used to determine the extent of the disease if a cancer comes back after treatment. Recurrence or retreatment staging helps determine the best treatment options for cancer that has returned.  

Restaging may also be done to find out how the cancer responded to treatment. If restaging is done and a new stage is assigned, the new stage will be marked with an “r” in front of it to show that it’s different from the original stage. Usually, the original stage stays the same, even if the cancer comes back or gets worse. The same tests that were carried out to diagnose the cancer are usually carried out again. Restaging helps doctors plan the best treatment for cancer that has come back or become worse.

Staging Models

There are two main staging systems in use, AJCC and ENETs. Both are based on the TNM Staging System although the content may differ. 

What Is the TNM Staging System?

The TNM Staging System was developed and is maintained by the AJCC and the Union for International Cancer Control (UICC). It is the most commonly used staging system by medical professionals around the world. The TNM classification system was developed as a tool for doctors to stage different types of cancer based on certain, standardised criteria. Please note with different TNM models, there could be different stage descriptions depending on the location of the primary tumour and similarly different TNM models for different tumour locations. Although most seem to synchronise, this is a really important point for Neuroendocrine Neoplasms (NENs) interpretation due to their multiple primary locations. 

The TNM Staging System includes the extent of the tumor (T), extent of spread to the lymph nodes (N), and presence of metastasis (M).

The T category describes the original (primary) tumor.

TX

Primary tumor cannot be evaluated

T0

No evidence as primary tumor

Tis

Carcinoma in situ (early cancer that has not spread to neighboring tissue)

T1–T4

Size and/or extent of the primary tumor

The N category describes whether or not the cancer has reached nearby lymph nodes

NX

Regional lymph nodes cannot be evaluated

N0

No regional lymph node involvement (no cancer found in the lymph nodes)

N1-N3

Involvement of regional lymph nodes (number and/or extent of spread)

The M category tells whether there are distant metastases (spread of cancer to other parts of the body).

M0

No distant metastasis (cancer has not spread to other parts of the body)

M1

Distant metastasis (cancer has spread to distant parts of the body)

Because each cancer type has its own classification system, letters and numbers do not always mean the same thing for every kind of cancer. Once the T, N, and M are determined, they are combined and an overall stage of 0, I, II, III, IV is assigned. Sometimes these stages are subdivided using letters such as IIIA and IIIB.

Staging of NETs

As above, each cancer type has a different staging definition based on the TNM template.  NENs are unique in that there are multiple types based on different organs. Consequently each NEN type has its own staging definition.  NEN staging is therefore more complex than most other cancer types.

Access to AJCC and ENETS staging info is difficult, normally behind a paywall and only accessible to healthcare professionals.  However,  there are some sites providing useful and up to date extracts.  To those reading, it’s worth pointing out that certain NET types may have different TNM definitions in AJCC and ENETS although most are synchronised. 

Until this is more publicly available, I will use one of these sources which I know is kept up to date. They also quite often quote from both AJCC and ENETS when there are differences. Click as required.

Appendix NET

Gastric NET

Small Intestine NET

Pancreatic NET

Duodenal NET

Colon and Rectal NET

Lung NET (use Lung Cancer staging definitions).  

Pheochromocytoma/Paraganglioma

I will update as I find it.  Neuroendocrine Carcinoma (NEC) is more complex, I’m working on it. Also working on access to ENETS. 

Miscellaneous Pathology terms supporting TNM

You may see some letters preceding or succeeding TNM data.  The most common are listed here. 

Optional descriptors
Pn – Perineural invasion 
PnXPerineural invasion cannot be assessed
Pn0No perineural invasion
Pn1Perineural invasion
L – Lymphatic invasion 
LXLymphatic invasion cannot be assessed
L0No lymphatic invasion
L1Lymphatic invasion
V – Venous invasion 
VXVenous invasion cannot be assessed
V0No venous invasion
V1Microscopic venous invasion
V2Macroscopic venous invasion

Prefix modifiers

  • c: stage is determined from evidence acquired before treatment (including clinical examination, imaging, endoscopy, biopsy, surgical exploration). The c-prefix is implicit in absence of the p-prefix.
  • p: stage given by histopathologic examination of a surgical specimen
  • y: stage assessed after chemotherapy and/or radiation therapy; in other words, the individual had neoadjuvant therapy.
  • r: stage for a recurrent tumor in an individual that had some period of time free from the disease.
  • a: stage determined at autopsy.
  • m: tumor is multifocal (more than 1 tumors). The opposite, s, can be used when there is particular reason to emphasize that the tumor is solitary/single.

References;

  1. The Eighth Edition AJCC Cancer Staging Manual (p.s Ninth edition being rolled out 2024 and NET is front of the line!).
  2. ENETS
  3. Pathology Outlines

Now read about Grade and the WHO 2022 Classification

Click here or on the graphic below

Click the picture to read more

Disclaimer

I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me. 

Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional.   

Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.

Click picture to subscribe

Thanks for reading.

Ronny

Personal Facebook. Like this page please.
Blog Facebook. Like this page please.
Awareness Facebook Like this page please.

Sign up for my newsletters – Click Here

Disclaimer

My Diagnosis and Treatment History

Follow me on twitter

Check out my online presentations

Check out my WEGO Health Awards

Check out my Glossary of Terms – click here

patients included

Please Share this post for Neuroendocrine Cancer awareness and to help another patient

 
 
 
Facebook
Twitter
Pinterest
WhatsApp
Email

Carcinoid vs Neuroendocrine

OPINION  – There’s a constant debate regarding the validity of the term ‘Carcinoid‘.  I’ve posted about this a few times and as far as I know,

Read More »
Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 14.5K other subscribers

A cup of tea


I would also mention those who contributed to my “Tea Fund” which resides on PayPal.  You don’t need a PayPal account as you can select a card but don’t forget to select the number of units first (i.e. 1 = £4, 2 = £8, 3 = £12, and so on), plus further on, tick a button to NOT create a PayPal account if you don’t need one.  Clearly, if you have a PayPal account, the process is much simpler 

Through your generosity, I am able to keep my sites running and provide various services for you.  I have some ideas for 2023 but they are not detailed enough to make announcements yet. 

This screenshot is from every single post on my website and depending on which machine you are using, it will either be top right of the post or at the bottom (my posts are often long, so scroll down!)


Discover more from Ronny Allan - Living with Neuroendocrine Cancer

Subscribe to get the latest posts to your email.

Staging of Neuroendocrine Neoplasms (NENs)
By Ronny Allan

Ronny Allan is an award-winning international patient leader advocating for Neuroendocrine Cancer and cancer patients generally. Check out his Facebook pages and twitter accounts.

I love comments - feel free!

Related Posts

Discover more from Ronny Allan - Living with Neuroendocrine Cancer

Subscribe now to keep reading and get access to the full archive.

Continue reading

Discover more from Ronny Allan - Living with Neuroendocrine Cancer

Subscribe now to keep reading and get access to the full archive.

Continue reading

Verified by MonsterInsights